Psychopharmacology of topiramate: from epilepsy to bipolar disorder

References

• AllisonDBMentoreJLHeoM1999Antipsychotic-induced weight gain: a comprehensive research synthesisAm J Psychiatry15616869610553730
   PubMed Web of Science ®Google Scholar
• BahkWMShinYCWooJM2005Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label studyProg Neuropsychopharmacol Biol Psychiatry291152115610953
   PubMed Web of Science ®Google Scholar
• BartholiniG1985GABA receptor agonists: pharmacological spectrum and therapeutic actionsMed Res Rev555752984490
   PubMed Web of Science ®Google Scholar
• BirtJ2003Management of weight gain associated with antipsychoticsAnn Clin Psychiatry15495812839432
   PubMedGoogle Scholar
• BitonVMontourisGDRitterF1999A study of topiramate in primary generalized tonic-clonic seizuresNeurology521330710227614
   PubMed Web of Science ®Google Scholar
• BowdenCLBruggerAMSwannAC1994Efficacy of divalproex vs. lithium and placebo in the treatment of maniaJ Am Med Assoc27191824
   PubMed Web of Science ®Google Scholar
• BowdenCLCalabreseJRMcElroySL2000A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study GroupArch Gen Psychiatry57481910807488
   PubMed Web of Science ®Google Scholar
• BowdenCLCalabreseJRSachsG2003A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorderArch Gen Psychiatry6039240012695317
   PubMed Web of Science ®Google Scholar
• BozikasVPPetrikisPKourtisA2002Treatment of acute mania with topiramate in hospitalized patientsProg Neuropsychopharmacol Biol Psychiatry261203612452547
   PubMed Web of Science ®Google Scholar
• BremnerJDNarayanMAndersonER2000Hippocampal volume reduction in major depressionAm J Psychiatry1571151810618023
   PubMed Web of Science ®Google Scholar
• BrownSDWolfHHSwinyardEA1993The novel anticonvulsant topiramate enhances GABA-mediated chloride fluxEpilepsia341223
   Google Scholar
• CalabreseJRFaterniSHKujawaM1996Predictors of response to mood stabilizersJ Clin Psychopharmacol16Suppl 12431
   Web of Science ®Google Scholar
• CalabreseJRBowdenCLSachsG1999A double blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depressionJ Clin Psychiatry60798810084633
   PubMed Web of Science ®Google Scholar
• CalabreseJRKeckPEJrMcElroySL2001A pilot study of topiramate as monotherapy in the treatment of acute maniaJ Clin Psychopharmacol21340211386499
   PubMed Web of Science ®Google Scholar
• ChengappaKNRRathoreDLevineJ1999Topiramate as add-on treatment for patients with bipolar maniaBipolar Disord1425311256656
   PubMedGoogle Scholar
• ChengappaKNGershonSLevineJ2001The evolving role of topiramate among other mood stabilizers in the management of bipolar disorderBipolar Disord32153211912568
   PubMed Web of Science ®Google Scholar
• ChengappaKNChalasaniLBrarJS2002Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart reviewClin Ther2415768412462287
   PubMed Web of Science ®Google Scholar
• CoulterDASombatiSDeLorenzoRJ1993Selective effects of topiramate on sustained repetitive firing and spontaneous bursting in cultured hippocampal neuronsEpilepsia34Suppl 2123
   Google Scholar
• CoulterDASombatiSDeLorenzoRJ1995Topiramate effects on excitatory amino acid-mediated responses in cultured hippocampal neurons: selective blockade of kainite currentsEpilepsia36Suppl 340
   Google Scholar
• CrawfordP1998An audit of topiramate use in a general neurology clinicSeizure7207119700833
   PubMed Web of Science ®Google Scholar
• D’AmicoDGrazziLBussoneG2006Topiramate in the prevention of migraine: a review of its efficacy, tolerability, and acceptibilityNeuropsychiatric Disease and Treatment22617
   Google Scholar
• DeLorenzoRJSombatiSCoulterDA2000Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neuronsEpilepsia41Suppl 1404
   PubMed Web of Science ®Google Scholar
• DenicoffKDSmith-JacksonEEDisneyER1997Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorderJ Clin Psychiatry5847089413412
   PubMed Web of Science ®Google Scholar
• DodgsonSJShankRPMaryanoffBE2000Topiramate as an inhibitor of carbonic anhydrase isoenzymesEpilepsia41Suppl 1359
   PubMed Web of Science ®Google Scholar
• DubovskySLBuzanRD1997Novel alternatives and supplements to lithium and anticonvulsants for bipolar affective disorderJ Clin Psychiatry58224429184620
   PubMed Web of Science ®Google Scholar
• DunnRTFryeMSKimbrellTA1998The efficacy and use of anticonvulsants in mood disordersClin Neuropharmacol21215359704164
   PubMed Web of Science ®Google Scholar
• EadsLKramerT2000Effects of topiramate on global functioning in treatment-refractory mood disordersInt J Neuropsychopharmacol3Suppl 1340
   Google Scholar
• El MallakhRSJaziriWA1990Calcium channel blockers in affective illness: role of sodium-calcium exchangeJ Clin Psychopharmacol10203202165504
   PubMed Web of Science ®Google Scholar
• ErnstCLGoldbergJF2003Antidepressant properties of anticonvulsant drugs for bipolar disorderJ Clin Psychopharmacol231829212640220
   PubMed Web of Science ®Google Scholar
• EvinsAE2003Efficacy of newer anticonvulsant medications in bipolar spectrum mood disordersJ Clin Psychiatry64Suppl 891412892536
   PubMed Web of Science ®Google Scholar
• FaughtEWilderBJRamsayRE1996Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, 600-mg dosagesNeurology461684908649570
   PubMed Web of Science ®Google Scholar
• FreemanMPStollAL1998Mood stabilizer combinations: a review of safety and efficacyAm J Psychiatry15512219433333
   PubMed Web of Science ®Google Scholar
• FrodlTMeisenzahlEMZetzscheT2002Hippocampal changes in patients with a first episode of major depressionAm J Psychiatry15911121812091188
   PubMed Web of Science ®Google Scholar
• GanguliR1999Weight gain associated with antipsychotic drugsJ Clin Psychiatry6020410548138
   PubMed Web of Science ®Google Scholar
• GerberPEHamiwkaLConnollyMB2000Factors associated with behavioural and cognitive abnormalities in children receiving topiramatePediatr Neurol22200310734250
   PubMed Web of Science ®Google Scholar
• GibbsJWSombatiSDeLorenzoRI2000Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neuronsEpilepsia41Suppl 1101610643917
   PubMed Web of Science ®Google Scholar
• GitlinMJSwendsenJHellerTL1995Relapse and impairment in bipolar disorderAm J Psychiatry1521635407485627
   PubMed Web of Science ®Google Scholar
• GlauserTA1999TopiramateEpilepsia40Suppl 57180
   Web of Science ®Google Scholar
• GoldbergJFHarrowMGrossmanLS1995Course and outcome in bipolar affective disorder: a longitudinal follow-up studyAm J Psychiatry152379847864263
   PubMed Web of Science ®Google Scholar
• GordonAPriceLH1999Mood stabilization and weight loss with topiramateAm J Psychiatry156Suppl 6968910360144
   PubMed Web of Science ®Google Scholar
• GrunzeHCNormannCLangoschJ2001Antimanic efficacy of topiramate in 11 patients in an open trial with an on-off-on designJ Clin Psychiatry62464811465524
   PubMed Web of Science ®Google Scholar
• GrunzeHWaldenJ2002Relevance of new and newly rediscovered anticonvulsants for atypical forms of bipolar disorderJ Affect Disord72Suppl 1152112204313
   PubMed Web of Science ®Google Scholar
• GuilleCSachsG2002Clinical outcome of adjunctive topiramate treatment in a sample of refractory bipolar patients with comorbid conditionsProg Neuropsychopharmacol Biol Psychiatry261035912452523
   PubMed Web of Science ®Google Scholar
• HussainMZChaudhryZ1999Treatment of bipolar depression with topiramateEur Neuropsychopharmacol9Suppl 5222
   Google Scholar
• JochumTBärKJSauerH2002Topiramate induced manic episodeJ Neurol Neurosurg Psychiatry73202912122185
   PubMed Web of Science ®Google Scholar
• KaminM2002Topiramate: clinical efficacy and use in nonepileptic disordersLevyRHMattsonRHMeldrumBSAnti-epileptic drugs5th edPhiladelphiaLippincott Williams & Wilkins7539
   Google Scholar
• KeckPEJrMcElroySL1996Outcome in the pharmacologic treatment of bipolar disorderJ Clin Psychopharmacol161523
   PubMed Web of Science ®Google Scholar
• KellettMWSmithDFStocktonPA1999Topiramate in clinical practice: first year’s postlicensing experience in a specialist epilepsy clinicJ Neurol Neurosurg Psychiatry667596310329750
   PubMed Web of Science ®Google Scholar
• KetterTAPostRMTheodoreWH1999Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disordersNeurology53Suppl 25367
   PubMed Web of Science ®Google Scholar
• KetterTAWangPWBeckerOV2003The diverse role of anticonvulsants in bipolar disordersAnn Clin Psychiatry159510812938867
   PubMedGoogle Scholar
• KlufasAThompsonD2001Topiramate-induced depressionAm J Psychiatry158173611579016
   PubMed Web of Science ®Google Scholar
• KusumakarVYathamLKutcherS1999Preliminary, open-label study of topiramate in rapid-cycling bipolar womenEur Neuropsychopharmacol9357
   Google Scholar
• KuznieckyRHetheringtonHHoS1998Topiramate increases cerebral GABA in healthy humansNeurology5162799710056
   PubMed Web of Science ®Google Scholar
• LangtryHDGillisJCDavisR1997Topiramate: a review of its pharma-codynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsyDrugs54Suppl 5752739360061
   PubMed Web of Science ®Google Scholar
• LeppikI1995Tiagabine: the safety landscapeEpilepsia36Suppl 61013
   PubMed Web of Science ®Google Scholar
• LykourasLHatzimanolisJ2004Adjunctive topiramate in the maintenance treatment of bipolar disorders: an open-label studyCurr Med Res Opin20843715200741
   PubMed Web of Science ®Google Scholar
• MaidmentID2002The use of topiramate in mood stabilizationAnn Pharmacother3612778112086564
   PubMed Web of Science ®Google Scholar
• ManjiHKLenoxRH2000The nature of bipolar disorderJ Clin Psychiatry61Suppl 13425711153812
   PubMed Web of Science ®Google Scholar
• MarcotteD1998Use of topiramate, a new anti-epileptic as a mood stabilizerJ Affect Disord50245519858083
   PubMed Web of Science ®Google Scholar
• MartinRKuznieckyRHoS1999Cognitive effects of topiramate, gabapentin and lamotrigine in healthy young adultsNeurology5232179932951
   PubMed Web of Science ®Google Scholar
• McElroySLSuppesTKeckPE2000Open-label adjunctive topiramate in the treatment of bipolar disordersBiol Psychiatry4710253310862801
   PubMed Web of Science ®Google Scholar
• McIntyreRSManciniDAMcCannSM2002Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind studyBipolar Disord42071312180276
   PubMed Web of Science ®Google Scholar
• McLeanMJBukhariAAWamilAW2000Effects of topiramate on sodium-dependent action-potential firing by mouse spinal cord neurons in cell cultureEpilepsia41Suppl 1212411156505
   PubMed Web of Science ®Google Scholar
• MikaeloffYde Saint-MartinAManciniJ2003Topiramate: efficacy and tolerability in children according to epilepsy syndromesEpilepsy Res532253212694931
   PubMed Web of Science ®Google Scholar
• MulaMTrimbleMRLhatooSD2003aTopiramate and psychiatric adverse events in patients with epilepsyEpilepsia446596312752464
   PubMed Web of Science ®Google Scholar
• MulaMTrimbleMRSanderWAS2003bThe role of hippocampal sclerosis in topiramate-related depression and cognitive deficits in people with epilepsyEpilepsia441573714636330
   PubMed Web of Science ®Google Scholar
• MulaMTrimbleMRThompsonP2003cTopiramate and wordfinding difficulties in patients with epilepsyNeurology601104712682314
   PubMed Web of Science ®Google Scholar
• NemeroffCB2003Safety of available agents used to treat bipolar disorder: focus on weight gainJ Clin Psychiatry64532912755655
   PubMed Web of Science ®Google Scholar
• NortonJPotterDEdwardsK1997Sustained weight loss patterns with topiramateEpilepsia38Suppl 360
   Google Scholar
• O’ConnellRAMayoJAFlatowL1991Outcome of bipolar disorder on long-term treatment with lithiumBr J Psychiatry15912391888958
   PubMed Web of Science ®Google Scholar
• OsserDNNajarianDMDufresneRL1999Olanzapine increases weight and serum triglyceride levelsJ Clin Psychiatry607677010584766
   PubMed Web of Science ®Google Scholar
• PeruccaE1997A pharmacological and clinical review on topiramate, a new antiepileptic drugPharmacol Res35241569264038
   PubMed Web of Science ®Google Scholar
• PettyFKramerGLFultonM1993Low plasma GABA is a trait-like marker for bipolar illnessNeuropsychopharmacology9125328216695
   PubMed Web of Science ®Google Scholar
• PettyF1995GABA and mood disorders: a brief review and hypothesisJ Affect Disord34275818550953
   PubMed Web of Science ®Google Scholar
• PiesR2002Combining lithium and anticonvulsants in bipolar disorder: a reviewAnn Clin Psychiatry142233212630658
   PubMedGoogle Scholar
• PostRMUhdeTW1983Treatment of mood disorders with antiepileptic medications: clinical and theoretical implicationsEpilepsia24Suppl 197108
   Web of Science ®Google Scholar
• PostRMKetterTADenicoffK1996The place of anticonvulsant therapy in bipolar illnessPsychopharmacology Berl128115298956373
   PubMed Web of Science ®Google Scholar
• PostRMDenicoffKDFryeMA1998aA history of the use of anticonvulsants as mood stabilizers in the last two decades of the 20th centuryNeuropsychobiology38Suppl 3152669778604
   PubMed Web of Science ®Google Scholar
• PostRMFryeMADenicoffKD1998bBeyond lithium in the treatment of bipolar illnessNeuropsychopharmacology19206199653709
   PubMed Web of Science ®Google Scholar
• PostRMSpeerAM2002A brief history of anticonvulsant use in affective disordersTrimbleMRSchmitzBSeizures, affective disorders and anticonvulsant drugsGuilfordClarius Press5382
   Google Scholar
• PostRMWeissSR2004Convergences in course of illness and treatments of the epilepsies and recurrent affective disordersClin EEG Neurosci35142415112460
   PubMed Web of Science ®Google Scholar
• PriviteraMFinchamRPenryJ1996Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosagesNeurology461678838649569
   PubMed Web of Science ®Google Scholar
• PriviteraMD1997Topiramate: a new antiepileptic drugAnn Pharmacother311164739337443
   PubMed Web of Science ®Google Scholar
• ReifeRPledgerGWuS-C2000Topiramate as add-on therapy: pooled analysis of randomised controlled trials in adultsEpilepsia41Suppl 16671
   PubMedGoogle Scholar
• RoettgerVRAmaraSG1999GABA and glutamate transporters: therapeutic and etiologic implications for epilepsyAdv Neurol795516010514843
   PubMedGoogle Scholar
• RosenfeldWEHolmesGBHuntTL1992Topiramate: effective dosaging enhances potential for successEpilepsia33Suppl 3118
   Google Scholar
• RosenfeldWE1997Topiramate: a review of preclinical, pharmacokinetic, and clinical dataClin Ther1912943089444441
   PubMed Web of Science ®Google Scholar
• RosenfeldWESchaeferPAPaceK1997Weight loss patterns with topiramate therapyEpilepsia38Suppl 358
   Google Scholar
• SachdeoRCGlauserTARitterRC1999A double-blind, randomized trial of topiramate in Lennox-Gastaut syndromeNeurology521882710371538
   PubMed Web of Science ®Google Scholar
• SchlatterFJSoutulloCACervera-EnguixS2001First break of mania associated with topiramate treatmentJ Clin Psychopharmacol21464511476138
   PubMed Web of Science ®Google Scholar
• SchmitzB2002Depressive disorders in epilepsyTrimbleMRSchmitzBSeizures, affective disorders and anticonvulsant drugsGuilfordClarius Press1934
   Google Scholar
• SevertLCoulterDASombatiS1995Topiramate selectively blocks kainite currents in cultured hippocampal neuronsEpilepsia36Suppl 438
   Google Scholar
• ShankRPGardockiJFVaughtJL1994Topiramate: preclinical evaluation of a structurally novel anticonvulsantEpilepsia35450608156972
   PubMed Web of Science ®Google Scholar
• ShankRPGardockiJFStreeterAJ2000An overview of preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of actionEpilepsia41Suppl 139
   PubMed Web of Science ®Google Scholar
• ShorvonSD1996Safety of topiramate: adverse events and relationships to dosingEpilepsia37Suppl 21822
   Web of Science ®Google Scholar
• SilverstoneTRomansS1996Long term treatment of bipolar disordersDrugs51367828882376
   PubMed Web of Science ®Google Scholar
• SoaresJCGershonS2000The psychopharmacologic specificity of the lithium ion: origins and trajectoryJ Clin Psychiatry61162210826656
   PubMed Web of Science ®Google Scholar
• SpinaEPerugiG2004Antiepileptic drugs: indications other than epilepsyEpileptic Disord6577515246950
   PubMed Web of Science ®Google Scholar
• StollALSeverusWE1996Mood stabilizers: shared mechanisms of action at postsynaptic signal-transduction and kindling processesHarv Rev Psychiatry477899384977
   PubMed Web of Science ®Google Scholar
• SuppesT2002Review of the use of topiramate for treatment of bipolar disordersJ Clin Psychopharmacol2259960912454560
   PubMed Web of Science ®Google Scholar
• SwannACBowdenCLMorrisD1997Depression during mania: treatment response to lithium or divalproexArch Gen Psychiatry5437429006398
   PubMed Web of Science ®Google Scholar
• TatumWOFrenchJAMorrisGL2001Postmarketing experience with topiramate and cognitionEpilepsia321134114011580760
   PubMed Web of Science ®Google Scholar
• ThomasLTrimbleMSchmitzB1996Vigabatrin and behaviour disorders: retrospective surveyEpilepsy Res252178886658
   PubMed Web of Science ®Google Scholar
• Van KammenDPShankRP2002New anticonvulsants in affective disorder: topiramateTrimbleMRSchmitzBSeizures, affective disorders and anticonvulsant drugsGuilfordClarius Press14366
   Google Scholar
• VietaEGilabertARodriguezA2001Effectiveness and safety of topiramate in treatment-resistant bipolar disorderActas Esp Psiquiatr291485211412488
   PubMed Web of Science ®Google Scholar
• VietaETorrentCGarcia-RibasG2002Use of topiramate in treatment-resistant bipolar spectrum disordersJ Clin Psychopharmacol22431512172346
   PubMed Web of Science ®Google Scholar
• VietaESanchez-MorenoJGoikoleaJM2004Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorderJ Clin Psychopharmacol24374815232327
   PubMed Web of Science ®Google Scholar
• WassersteinAGRakIReifeRA1995Nephrolithiasis during treatment with topiramateEpilepsia36Suppl 3153
   Google Scholar
• WauquierAZhouS1996Topiramate: a potent anticonvulsant in the amygdala-kindled ratEpilepsy Res247378796355
   PubMed Web of Science ®Google Scholar
• WhiteHSBrownSDSkeenGA1995The investigational anticonvulsant topiramate potentiates GABA-evoked currents in mouse cortical neuronsEpilepsia3634
   Web of Science ®Google Scholar
• WhiteHSBrownSDWoodheadJH1997Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure thresholdEpilepsy Res28167799332882
   PubMed Web of Science ®Google Scholar
• WhiteHSBrownSDWoodheadJH2000Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanismEpilepsia41Suppl 11720
   PubMed Web of Science ®Google Scholar
• WhiteHS2002Topiramate: mechanisms of actionLevyRHMattsonRHMeldrumBSAntiepileptic drugs5th edPhiladelphiaLippincott Williams & Wilkins71926
   Google Scholar
• WirshingDAWirshingWCKysarL1999Novel antipsychotics: comparison of weight gain liabilitiesJ Clin Psychiatry603586310401912
   PubMed Web of Science ®Google Scholar
• WoodsTMEichnerSFFranksAS2004Weight gain mitigation with topiramate in mood disordersAnn Pharmacother388879115039481
   PubMed Web of Science ®Google Scholar
• YathamLNKusumakarVCalabreseJR2002Third generation anticonvulsants in bipolar disorder: a review of efficacy and summary of clinical recommendationsJ Clin Psychiatry632758312000201
   PubMed Web of Science ®Google Scholar
• YathamLN2004Newer anticonvulsants in the treatment of bipolar disorderJ Clin Psychiatry65Suppl 10283515242330
   PubMed Web of Science ®Google Scholar
• ZhangXVelumianAAJonesOT1998Topiramate reduces high-voltage activated Ca2+ currents in CA1 pyramidal neurons in vitroEpilepsia39Suppl 644
   Google Scholar
• ZhangXVelumianAAJonesOT2000Modulation of high-voltage activated calcium channels in dentate granule cells by topiramateEpilepsia41Suppl 1526010643924
   PubMed Web of Science ®Google Scholar